Literature DB >> 12627331

Heteroplasmic ratio of the A3243G mitochondrial DNA mutation in single pancreatic beta cells.

S Lynn1, G M Borthwick, R M Charnley, M Walker, D M Turnbull.   

Abstract

AIMS/HYPOTHESIS: To examine whether there is a high content of mutated mitochondrial DNA in individual pancreatic beta cells from a patient with the A3243G mitochondrial DNA mutation.
METHODS: Tissues were available from a patient with diabetes and the A3243G mutation including pancreatic tissue. We quantified the amount of mutated mitochondrial DNA in tissue homogenates and single pancreatic beta cells using hot last cycle PCR.
RESULTS: The percentage ratio of mutated to wild-type mtDNA was high in tissues such as muscle and brain (>60%), but surprisingly low in both pancreatic islets and in individual beta cells from these islets. The islets were smaller in the patient than in control subjects in keeping with a decreased beta-cell mass. CONCLUSIONS/
INTERPRETATION: These observations suggest that either the beta cells show increased sensitivity to the effects mtDNA mutations on respiratory chain function, and/or cells with a high mutant load are preferentially removed leading to a progressive decrease in the islet beta-cell mass.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12627331     DOI: 10.1007/s00125-002-1018-z

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  10 in total

1.  Nonrandom tissue distribution of mutant mtDNA.

Authors:  P F Chinnery; P J Zwijnenburg; M Walker; N Howell; R W Taylor; R N Lightowlers; L Bindoff; D M Turnbull
Journal:  Am J Med Genet       Date:  1999-08-27

2.  Very low levels of the mtDNA A3243G mutation associated with mitochondrial dysfunction in vivo.

Authors:  P F Chinnery; D J Taylor; D T Brown; D Manners; P Styles; R Lodi
Journal:  Ann Neurol       Date:  2000-03       Impact factor: 10.422

3.  Molecular and histological evaluation of pancreata from patients with a mitochondrial gene mutation associated with impaired insulin secretion.

Authors:  S Otabe; K Yasuda; Y Mori; K Shimokawa; H Kadowaki; A Jimi; K Nonaka; Y Akanuma; Y Yazaki; T Kadowaki
Journal:  Biochem Biophys Res Commun       Date:  1999-05-27       Impact factor: 3.575

4.  In situ characterization of islets in diabetes with a mitochondrial DNA mutation at nucleotide position 3243.

Authors:  T Kobayashi; K Nakanishi; H Nakase; H Kajio; M Okubo; T Murase; K Kosaka
Journal:  Diabetes       Date:  1997-10       Impact factor: 9.461

5.  Diagnosis of mitochondrial disease: assessment of mitochondrial DNA heteroplasmy in blood.

Authors:  R W Taylor; G A Taylor; C M Morris; J M Edwardson; D M Turnbull
Journal:  Biochem Biophys Res Commun       Date:  1998-10-29       Impact factor: 3.575

Review 6.  Molecular and clinical aspects of mitochondrial diabetes mellitus.

Authors:  J A Maassen; E van Essen; J M van den Ouweland; H H Lemkes
Journal:  Exp Clin Endocrinol Diabetes       Date:  2001       Impact factor: 2.949

Review 7.  Mitochondrial function in normal and diabetic beta-cells.

Authors:  P Maechler; C B Wollheim
Journal:  Nature       Date:  2001-12-13       Impact factor: 49.962

8.  Extremely high levels of mutant mtDNAs co-localize with cytochrome c oxidase-negative ragged-red fibers in patients harboring a point mutation at nt 3243.

Authors:  V Petruzzella; C T Moraes; M C Sano; E Bonilla; S DiMauro; E A Schon
Journal:  Hum Mol Genet       Date:  1994-03       Impact factor: 6.150

9.  Impaired insulin secretion and beta-cell loss in tissue-specific knockout mice with mitochondrial diabetes.

Authors:  J P Silva; M Köhler; C Graff; A Oldfors; M A Magnuson; P O Berggren; N G Larsson
Journal:  Nat Genet       Date:  2000-11       Impact factor: 38.330

10.  Study of mitochondrial DNA depletion in muscle by single-fiber polymerase chain reaction.

Authors:  M Sciacco; P Gasparo-Rippa; T H Vu; K Tanji; S Shanske; J R Mendell; E A Schon; S DiMauro; E Bonilla
Journal:  Muscle Nerve       Date:  1998-11       Impact factor: 3.217

  10 in total
  15 in total

1.  Diabetes-associated mitochondrial DNA mutation A3243G impairs cellular metabolic pathways necessary for beta cell function.

Authors:  P B M de Andrade; B Rubi; F Frigerio; J M W van den Ouweland; J A Maassen; P Maechler
Journal:  Diabetologia       Date:  2006-05-31       Impact factor: 10.122

2.  Age-related decline in mitochondrial DNA copy number in isolated human pancreatic islets.

Authors:  L M Cree; S K Patel; A Pyle; S Lynn; D M Turnbull; P F Chinnery; M Walker
Journal:  Diabetologia       Date:  2008-06-05       Impact factor: 10.122

Review 3.  Neuropathological aspects of mitochondrial DNA disease.

Authors:  Joanne Betts; Robert N Lightowlers; Douglass M Turnbull
Journal:  Neurochem Res       Date:  2004-03       Impact factor: 3.996

4.  Purifying Selection against Pathogenic Mitochondrial DNA in Human T Cells.

Authors:  Melissa A Walker; Caleb A Lareau; Leif S Ludwig; Amel Karaa; Vijay G Sankaran; Aviv Regev; Vamsi K Mootha
Journal:  N Engl J Med       Date:  2020-08-12       Impact factor: 91.245

5.  Systematic segregation to mutant mitochondrial DNA and accompanying loss of mitochondrial DNA in human NT2 teratocarcinoma Cybrids.

Authors:  Carrie J Turner; Caroline Granycome; Rachel Hurst; Elizabeth Pohler; M Katariina Juhola; Martti I Juhola; Howard T Jacobs; Lesley Sutherland; Ian J Holt
Journal:  Genetics       Date:  2005-06-08       Impact factor: 4.562

Review 6.  Applying genomic and transcriptomic advances to mitochondrial medicine.

Authors:  William L Macken; Jana Vandrovcova; Michael G Hanna; Robert D S Pitceathly
Journal:  Nat Rev Neurol       Date:  2021-02-23       Impact factor: 42.937

7.  Age-related mitochondrial DNA depletion and the impact on pancreatic Beta cell function.

Authors:  Donna L Nile; Audrey E Brown; Meutia A Kumaheri; Helen R Blair; Alison Heggie; Satomi Miwa; Lynsey M Cree; Brendan Payne; Patrick F Chinnery; Louise Brown; David A Gunn; Mark Walker
Journal:  PLoS One       Date:  2014-12-22       Impact factor: 3.240

8.  MitoRS, a method for high throughput, sensitive, and accurate detection of mitochondrial DNA heteroplasmy.

Authors:  Julien Marquis; Gregory Lefebvre; Yiannis A I Kourmpetis; Mohamed Kassam; Frédéric Ronga; Umberto De Marchi; Andreas Wiederkehr; Patrick Descombes
Journal:  BMC Genomics       Date:  2017-04-26       Impact factor: 3.969

9.  Prevalence and progression of diabetes in mitochondrial disease.

Authors:  R G Whittaker; A M Schaefer; R McFarland; R W Taylor; M Walker; D M Turnbull
Journal:  Diabetologia       Date:  2007-07-26       Impact factor: 10.122

Review 10.  Endocrine disorders in mitochondrial disease.

Authors:  Andrew M Schaefer; Mark Walker; Douglass M Turnbull; Robert W Taylor
Journal:  Mol Cell Endocrinol       Date:  2013-06-13       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.